• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings

    1/13/26 9:00:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care
    Get the next $BAX alert in real time by email
    • Versatile, scalable design allows a range of procedures to be performed in-stretcher, reducing the need for unnecessary patient transfers
    • Integrates advanced, connected technologies to support patient safety and help prevent falls
    • Launching in the U.S. with select geographic expansion planned later this year

    Baxter International Inc. (NYSE:BAX), an innovator in smart beds for med-surg and the intensive care unit, announced at the 2026 J.P. Morgan Healthcare Conference the upcoming U.S. launch of the Dynamo Series stretcher. The Dynamo Series is a stretcher designed to help alleviate the physical and cognitive burden on care teams1 and make it easier for them to focus on patient care, while improving the patient's experience. Intended for use in emergency departments, perioperative environments and patient transport services, the Dynamo Series is the latest innovation in Baxter's leading portfolio of smart beds, surfaces and connected care solutions.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112252075/en/

    Dynamo Series, Baxter International Inc.

    Dynamo Series, Baxter International Inc.

    "At Baxter, we are committed to driving focused innovation that empowers clinicians to deliver exceptional patient care in high-pressure environments," said James Teaff, president of Care & Connectivity Solutions at Baxter. "The stretcher is a vital bridge between care teams and patients. We designed the Dynamo Series to strengthen these connections by addressing some of the toughest challenges care teams face,2 including reducing the need for patient transfers and simplifying patient positioning across a range of procedures."3

    The Dynamo Series is intended to help enhance the care team experience, prevent patient falls and improve patient safety and comfort.

    • Enhance the care team experience: For certain procedures, care teams are often required to spend time transferring the patient from a standard stretcher to a specialty stretcher, which can create physical strain on the care team and increase the patient's risk of injury. The Dynamo Series is designed to help minimize the need for patient transfers3 with integrated stirrups that offer alternative patient positioning options and allow care teams to perform a range of procedures in the stretcher, including obstetric, pelvic and other exams.3 A full electric suite supports easier patient handling with multiple options for powered drive, height, head and knee adjustments, and an optional wireless connectivity offering enables delivery of select clinical safety and patient data to the patient's electronic medical record to help care teams monitor patients remotely.
    • Prevent patient falls: Each year, between 700,000 – 1 million people fall in U.S. hospitals, which can result in serious injuries and impacts to quality of life.4 The Dynamo Series features advanced technologies to help care teams anticipate risk and act quickly to reduce patient falls,5 while eliminating repetitive manual tasks to help ease their cognitive burden. These technologies include Baxter's SafeView+ system that projects visual cues indicating the safety status, a three-mode bed exit alarm system that provides real-time notifications and auto-rearm functionality.3 An optional connectivity offering allows direct integration with Baxter's Voalte Nurse Call and other systems, enabling real-time notifications to care teams.
    • Improve patient safety and comfort: The Dynamo Series offers one of the widest care surfaces currently available in the stretcher category6 to help care teams safely transfer patients and improve comfort across a range of patient sizes.7 Features including one-touch positioning controls, ability to convert to a true chair position and USB port for easy device charging offer greater autonomy for patients.1,3

    The Dynamo Series is now available for order in the U.S. and is expected to be available during the first half of 2026.

    About Baxter

    At Baxter, we are everywhere healthcare happens – and everywhere it is going, with essential solutions in the hospital, physician's office and other sites of care. For nearly a century, our customers have counted on us as a vital and trusted partner. And every day, millions of patients and healthcare providers rely on our unmatched portfolio of connected solutions, medical devices, and advanced injectable technologies. Approximately, 38,000 Baxter team members live our enduring mission: to save and sustain lives. Together, we are redefining how care is delivered to make a greater impact today, tomorrow, and beyond. To learn more, visit www.baxter.com and follow us on X, LinkedIn and Facebook.

    For safe and proper use of this device, please refer to the full Instructions for Use.

    This release includes forward-looking statements concerning potential benefits associated with the Dynamo Series and the anticipated timing of its release. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: demand for and market acceptance for new and existing products; product development risks; inability to create additional production capacity in a timely manner or the occurrence of other manufacturing or supply difficulties (including as a result of natural disasters, public health crises and epidemics/pandemics, regulatory actions or otherwise); satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities; product quality, manufacturing or supply, or patient safety issues; changes in law and regulations; and other risks identified in Baxter's most recent filing on Form 10-K and Form 10-Q and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.

    Baxter, Dynamo Series, Voalte and SafeView+ are trademarks of Baxter International Inc. or its subsidiaries.

    1 Data on file at Baxter International Inc. December 9, 2025.

    2 Data on file at Baxter International Inc. External Market Research Report. December 8, 2025.

    3 Dynamo Series Stretcher IFU. 220146 rev 1. December 19, 2025

    4 Agency for Healthcare Research and Quality: Preventing falls in hospitals. 2024

    5 Carle Health. Utilization of Fall Prevention Technologies in Hospital Beds. Posted Presented September 2025.

    6 Data on file at Baxter International Inc. December 9, 2025.

    7 Wiggermann et al., (2017). What Bed Size Does a Patient Need? The Relationship Between Body Mass Index and Space Required to Turn in Bed. Nursing Research, 66(6), 483-489.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260112252075/en/

    Media Contact:

    Sandrine Nadaud, (224) 948-5353

    [email protected]



    Investor Contact:

    Kevin Moran, (224) 507-3759

    [email protected]

    Get the next $BAX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BAX

    DatePrice TargetRatingAnalyst
    10/31/2025Buy → Hold
    Argus
    8/4/2025$25.00Buy → Hold
    Stifel
    8/1/2025$25.00Buy → Neutral
    Goldman
    2/26/2025$42.00Buy
    Goldman
    2/24/2025Hold → Buy
    Argus
    2/20/2025$39.00Overweight
    Barclays
    7/15/2024$39.00 → $30.00Equal-Weight → Underweight
    Morgan Stanley
    5/30/2024$36.00Neutral
    Goldman
    More analyst ratings

    $BAX
    SEC Filings

    View All

    Baxter International Inc. filed SEC Form 8-K: Other Events

    8-K - BAXTER INTERNATIONAL INC (0000010456) (Filer)

    12/22/25 4:59:44 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - BAXTER INTERNATIONAL INC (0000010456) (Filer)

    12/4/25 4:15:43 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - BAXTER INTERNATIONAL INC (0000010456) (Filer)

    11/25/25 4:45:37 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Baxter downgraded by Argus

    Argus downgraded Baxter from Buy to Hold

    10/31/25 8:47:22 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter downgraded by Stifel with a new price target

    Stifel downgraded Baxter from Buy to Hold and set a new price target of $25.00

    8/4/25 8:18:58 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter downgraded by Goldman with a new price target

    Goldman downgraded Baxter from Buy to Neutral and set a new price target of $25.00

    8/1/25 8:11:11 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief HR Officer Mason Jeanne K covered exercise/tax liability with 650 shares, decreasing direct ownership by 0.32% to 199,853 units (SEC Form 4)

    4 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)

    12/16/25 4:06:15 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    New insider Soriano Maria Cecilia claimed ownership of 54,623 shares (SEC Form 3)

    3 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)

    12/10/25 9:18:08 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Baxter International Inc.

    4 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)

    12/3/25 4:04:17 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings

    Versatile, scalable design allows a range of procedures to be performed in-stretcher, reducing the need for unnecessary patient transfers Integrates advanced, connected technologies to support patient safety and help prevent falls Launching in the U.S. with select geographic expansion planned later this year Baxter International Inc. (NYSE:BAX), an innovator in smart beds for med-surg and the intensive care unit, announced at the 2026 J.P. Morgan Healthcare Conference the upcoming U.S. launch of the Dynamo Series stretcher. The Dynamo Series is a stretcher designed to help alleviate the physical and cognitive burden on care teams1 and make it easier for them to focus on patient ca

    1/13/26 9:00:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges

    MUSC Health and Baxter International Inc. (NYSE:BAX), a global medtech leader, are entering into a multi-year strategic partnership that aims to enhance the high-quality and safe patient care already delivered at MUSC Health, MUSC's health care system, through integrated connected care technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108293816/en/ By leveraging Baxter's cutting-edge solutions and MUSC Health's clinical and academic expertise, the partnership aims to help drive further improvements in nurse satisfaction and retention, elevate quality and safety outcomes, and pave the way for future innovations in c

    1/8/26 9:00:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter to Present at J.P. Morgan 2026 Healthcare Conference

    Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the J.P. Morgan 2026 Healthcare Conference on Monday, January 12, 2026. Andrew Hider, Baxter's president and chief executive officer, is scheduled to present at 2:15 p.m. Pacific Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Saturday, July 11, 2026. About Baxter At Baxter, we are everywhere healthcare happens – and everywhere it is going, with essential solutions in the hospital, physician's office and other sites of care. For nearly a century, our customers have counted on us as a vital and trusted partner. And every day, millions

    1/6/26 5:14:00 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    Leadership Updates

    Live Leadership Updates

    View All

    Baxter Appoints Andrew Hider Chief Executive Officer

    Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a member of its board of directors. Mr. Hider will assume his responsibilities at Baxter no later than Sept. 3, 2025, or an earlier date pending completion of his current employment commitments. Brent Shafer, who has served as chair and interim CEO since February 2025, will then transition to independent chair of the Baxter Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250706840140/en/Andrew Hider Appointed Baxter's Next CEO Since 2017, Mr. Hider has served as

    7/7/25 8:35:00 AM ET
    $ATS
    $BAX
    Industrial Machinery/Components
    Industrials
    Medical/Dental Instruments
    Health Care

    Amerant Bancorp Announces Appointment of Two New Board Members

    Amerant Bancorp Inc. (NYSE:AMTB) ("Amerant" or "the Company") and its subsidiary, Amerant Bank, N.A. (the "Bank"), today announced the appointment of two accomplished executives, Patricia "Patty" Morrison and Jack Kopnisky, to the Board of Directors of the Company and the Bank. Their addition reflects the Company's continued commitment to strategic growth and further strengthening of the Board of Directors and executive management. "We are delighted to welcome both Patty and Jack to our Board of Directors," said Jerry Plush, Chairman and CEO of Amerant and the Bank. "Patty's deep technology leadership and extensive board expertise, paired with Jack's enviable experience in leading high pe

    6/24/25 9:20:00 AM ET
    $AMTB
    $BAX
    $WBS
    Major Banks
    Finance
    Medical/Dental Instruments
    Health Care

    PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

    Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience PureTech Health plc (NASDAQ:PRTC, LSE: PRTC)) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, ("Seaport") a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that Robert "Bob" J. Hombach has been appointed to its Board of Directors and will serve as the Chair of the Audit Committee. Mr. Hombach is a seasoned financial and operational executive with three decades of high-level leadership in the healthca

    3/11/25 7:05:00 AM ET
    $BAX
    $BMRN
    $EMBC
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Medical Specialities

    $BAX
    Financials

    Live finance-specific insights

    View All

    Baxter Announces Pricing of Tender Offers for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

    Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced the consideration payable in connection with the previously announced cash tender offers for the 2026 Notes and 2027 Notes (each as defined below). The table below sets forth the Total Consideration (as defined below) for each series of Notes. Title of Security CUSIP Number(1) Principal Amount Outstanding U.S. Treasury Reference Security Bloomberg Reference Page Reference Yield Fixed Spread Early Tender Payment (3)(4) Total Consideration(3)(4) 2.600% Senior Unsecured Notes due 2026 071813BQ1 $750,000,000 UST 1.500% due Aug. 15, 2026 FIT3 3.713% +30 bps $30

    12/4/25 4:15:00 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

    Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced the early tender results for the previously announced cash tender offers for the 2026 Notes and 2027 Notes (each as defined below). The tender offers are being made pursuant to the terms and conditions set forth in the offer to purchase, dated Nov. 19, 2025, as amended by the Company's press release dated Nov. 19, 2025 (as it may be further amended or supplemented from time to time, the "Offer to Purchase"). The tender offers comprise Baxter's offer to purchase for cash (a) any and all of its 2.600% senior unsecured notes due 2026 (the "2026 Notes") (the "Any and All Tender Offer") and (b) a portion of its 1.9

    12/4/25 7:51:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter Announces Increase in Maximum Tender Cap for 1.915% Senior Notes Due 2027

    Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced that it has increased the maximum purchase price for its $1.45 billion aggregate principal amount outstanding of 1.915% Senior Unsecured Notes due 2027 (the "2027 Notes") that it can repurchase under its previously announced cash tender offer for the 2027 Notes (the "2027 Notes Tender Offer") from $300 million to $600 million, on the terms and subject to the conditions set forth in the related Offer to Purchase dated Nov. 19, 2025 (the "Offer to Purchase"). The terms of the previously announced cash tender offer by Baxter for its 2.600% Senior Unsecured Notes due 2026 (the "2026 Notes Tender Offer" and, togethe

    11/19/25 4:15:00 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Baxter International Inc.

    SC 13G/A - BAXTER INTERNATIONAL INC (0000010456) (Subject)

    11/13/24 1:08:27 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Baxter International Inc. (Amendment)

    SC 13G/A - BAXTER INTERNATIONAL INC (0000010456) (Subject)

    2/13/24 5:00:53 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Baxter International Inc.

    SC 13G - BAXTER INTERNATIONAL INC (0000010456) (Subject)

    2/13/24 1:08:57 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care